Connect with us

Health

Boosting the Brain’s Mitochondria to Try to Halt Parkinson’s – Genetic Engineering & Biotechnology News

UK charity provides £1.2 million ($1.7 million) in funding to refine molecule to protect dopamine-producing brain cells and slow down disease progression.

Published

on

Article feature image

Parkinsons UK reports that it is investing up to £1.2 million into a one-year project in partnership with the University of Sheffield that aims to refine a molecule that could be developed into a drug to protect dopamine-producing brain cells and slow down the progression of Parkinson’s.
The funding boost comes via the charitys Parkinson’s Virtual Biotech initiative, which is fast-tracking the development of new treatments for people with Parkinsons. Scientists at the University of Sheffields Institute…

Click here to view the original article.

Continue Reading
Advertisement
Advertisement

Trending